S29 GPCR Modulators of Beta Cell Survival and Function

Program: Symposia
Basic/Translational Session
Friday, March 6, 2015: 9:30 AM-11:00 AM
Room 24 (San Diego Convention Center)
**This session is NOT eligible for CME credit**

Chair:
David A D'Alessio, MD, Univ of Cincinnati, Cincinnati, OH

Disclosures:
DAD: Consultant, Eli Lilly & Company, Consultant, Jansen Pharmaceuticals, Consultant, Merck & Co., Consultant, Novo Nordisk, Consultant, Proctor & Gamble, Consultant, Roche Pharmaceuticals, Consultant, Sanofi.
9:30 AM
James Neville Leonard, Ph.D., Cardiovascular and Metabolic Therapeutic Area, Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, PA
Disclosure: JNL: Employee, Johnson &Johnson.
10:00 AM
Marcy Guerra, PhD, StemSynergy Therapeutics, Inc., Franklin, TN
Nothing to Disclose: MG
10:30 AM
Joel Francis Habener, Medicine, Mass Gen Hosp, Boston, MA
Nothing to Disclose: JFH
See more of: Symposia